ORLANDO, Fla.--(BUSINESS WIRE)--LENSAR, Inc., a global leader in next generation femtosecond laser technology for refractive cataract surgery, today announced it has received 510k clearance from the U.S. Food and Drug Administration (FDA) for a suite of five new application technologies integrated into the company’s flagship product, the LENSAR Laser System. The LENSAR Laser System with Streamline™ is the first femtosecond laser cataract platform to enable automation of several surgical procedure planning and execution elements with the introduction of five new application upgrades that include:
Wireless integration with the Cassini Corneal Shape Analyzer
Iris registration
Cataract density imaging
Customized fragmentation patterns
Arcuate incision planning
Help employers find you! Check out all the jobs and post your resume.